Chutes & Ladders—Invivyd’s chairman adds CEO role ahead of COVID readout September 3, 2026Posted inBiotechnology Infectious-disease biotech Invivyd has appointed its current chairman, Marc Elia, as CEO. Post navigation Previous Post PD-L1 Emerges as Key Survival Marker in Aggressive Canine Gastric CancerNext PostThe Analytical Blueprint for Cell & Gene Therapy Success